Humacyte, Inc. (NASDAQ:HUMAW – Get Free Report) shot up 0.6% during mid-day trading on Friday . The company traded as high as $0.90 and last traded at $0.89. 13,050 shares were traded during mid-day trading, a decline of 7% from the average session volume of 14,034 shares. The stock had previously closed at $0.88.
Humacyte Stock Up 0.6 %
The stock’s fifty day moving average price is $1.34 and its 200-day moving average price is $1.62.
Humacyte Company Profile
Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.
Featured Articles
- Five stocks we like better than Humacyte
- Why Invest in 5G? How to Invest in 5G Stocks
- How to Build the Ultimate Everything ETF Portfolio
- Stock Average Calculator
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Stock Dividend Cuts Happen Are You Ready?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with MarketBeat.com's FREE daily email newsletter.
